Perspective Therapeutics (CATX) Interest & Investment Income (2010 - 2026)
Perspective Therapeutics (CATX) reported Interest & Investment Income of $2.35 million for Q2 2026, up 8.7% from $2.16 million a year earlier and up 6.8% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Interest & Investment Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Perspective Therapeutics' Interest & Investment Income came in at $9.09 million, down 15.6% year-over-year; for FY2025, it came in at $8.11 million, down 22.8% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 206.5% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $10.52 million in FY2024, $934,000 in FY2023 (+51.1%), $618,000 in FY2022 and $59,000 in FY2021 (+96.7%).
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income since Q1 2025.
- Year over year, Interest & Investment Income gained in two of the last four quarters, with growth averaging 17.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Perspective Therapeutics | 313.74 Mn | 313.74 Mn | - | 2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 62,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Jun 30, 2023 | 294,000.00 |
| Mar 31, 2023 | 374,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 5,000.00 |
API Access
Perspective Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();